Ascendis Pharma AS

NAS:ASNDHealthcareNASDAQ:NBISTOXX:EDD24BP

——At close · Market cap — · Next earnings Wed 11 Nov

ASND · Ratios · TradingHolo

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	54.7%	76.3%	83.4%	87.8%	85.1%	—	—
Operating margin	−4,755.1%	−5,808.6%	−1,097.9%	−170.8%	−76.7%	−18.9%	−18.9%	+0.0 pts
Net margin	−6,025.5%	−4,931.6%	−1,139.6%	−180.5%	−104.0%	−31.7%	−31.7%	+0.0 pts
EBITDA margin	−5,865.2%	−4,688.1%	−1,034.1%	−154.2%	−79.8%	−15.9%	—	—
Return on equity	−50.0%	−43.4%	−221.5%	330.4%	357.7%	134.6%	134.6%	+0.0 pts
Return on assets	−42.8%	−35.4%	−53.5%	−58.3%	−32.1%	−16.8%	−16.8%	+0.0 pts
Return on capital employed	−35.7%	−45.9%	−150.6%	−511.4%	−102.6%	−56.2%	—	—
Debt / equity	0.1×	0.2×	2.3×	−5.1×	−8.1×	−5.4×	−5.4×	+0.0%
Debt / assets	9.4%	19.3%	56.7%	90.0%	72.6%	66.9%	—	—
Interest coverage	−172.4×	−115.5×	−18.3×	−10.3×	−4.3×	−1.7×	—	—
Current ratio	14.0×	8.0×	1.3×	1.0×	1.2×	1.0×	1.0×	+0.0%
Quick ratio	14.0×	7.3×	1.1×	0.7×	0.8×	0.8×	—	—
Cash ratio	11.1×	4.4×	0.6×	0.5×	0.6×	0.6×	0.6×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.3×	0.3×	0.5×	—	—
Inventory turnover	—	0.0×	0.1×	0.2×	0.1×	0.3×	—	—
Receivables turnover	18.0×	3.5×	4.3×	7.4×	2.2×	4.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.